Chardan Capital downgraded shares of GenSight Biologics (OTCMKTS:GSGTF – Get Rating) from a buy rating to a neutral rating in a research note issued to investors on Thursday morning, The Fly reports. GenSight Biologics Stock Down 1.6 % Shares of GSGTF stock opened at $3.10 on Thursday. GenSight Biologics has a 12-month low of $3.10 […]
GenSight Biologics (OTCMKTS:GSGTF – Get Rating) was downgraded by stock analysts at Chardan Capital from a “buy” rating to a “neutral” rating in a research note issued on Thursday, The Fly reports. GenSight Biologics Stock Performance GenSight Biologics stock remained flat at $3.10 during midday trading on Thursday. GenSight Biologics has a 1 year low […]